Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

GB Group shares dive as FY results underwhelm

(Sharecast News) - Shares in GB Group took a dive on Tuesday despite the identity verification and fraud prevention software firm swinging to a full-year profit, as annual results a showed a slight slowdown in the second half. The company, which had already detailed its top-line results in a trading update in April, said revenues totalled £282.7m over the 12 months to 31 March, up 3.0% at constant currencies, compared with the 4.5% growth reported at the half-year stage.

As previously stated, adjusted operating profit rose 9.5% to £67.0m, helped by a 160-basis point improvement in the adjusted operating margin to 23.7%.

Statutory results, however, showed a headline pre-tax profit of £15.7m, compared with a loss of £50.4m the year before. Net debt was also reduced to just £48.5m from £80.9m, driven by strong cash conversion, while the final dividend was lifted 4.8% to 4.4p per share.

Looking ahead, the company said the new financial year has "begun as expected", and the outlook is consistent with market forecasts.

GB Group also said it intends to kickstart the required work needed to move from AIM to the Main Market - a decision which is said it "increasingly appropriate".

"The Board believes this proposed move will further enhance GBG's reputation with larger and more global customers in-line with its strategy to move into new geographies. In addition, the move should also increase GBG's access to a broader pool of capital from domestic and overseas investors. An update on the timing and process for the move will be provided in due course," said chief executive Dev Dhiman.

Shares were down nearly 10% at 245.02p by 0935 BST.

"While GBG's H225 was slightly weaker than anticipated, we have reviewed its growth credentials and think the recent product developments and ongoing reworking of its go-to-market strategy provide the potential for improvements to its organic growth rate and margins," said analysts at Berenberg, who initiated coverage of the stock on Tuesday with a 'buy' rating.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.